Bionano’s Commitment to ESG Practices
Bionano is focused on elevating health and wellness for all people through customer-centered innovations that transform the way the world sees the genome. While developing products and services to address unmet medical research needs is at the core of our focus, we also strive to have a positive impact on all our stakeholders – researchers, employees, stockholders, our community and vendors – as we work toward our mission. Bionano’s management is committed to executing various ESG initiatives across our organization and developing a strategy to guide our future efforts.
Bionano is pleased to issue our inaugural ESG overview, which showcases our current commitment to these initiatives. We will update our progress as we continue our ESG journey as part of our long-term business strategy.
Bionano is planning to publish its inaugural ESG report in the second half of 2023.